Noncytolytic inhibition of X4 virus by bulk CD8+ cells from human immunodeficiency virus type 1 (HIV-1)-Infected persons and HIV-1-Specific cytotoxic T lymphocytes is not mediated by β-chemokines

被引:32
作者
Geiben-Lynn, R
Kursar, M
Brown, NV
Kerr, EL
Luster, AD
Walker, BD
机构
[1] Partners AIDS Res Ctr, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02129 USA
[3] Harvard Univ, Sch Med, Boston, MA 02129 USA
关键词
D O I
10.1128/JVI.75.17.8306-8316.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) mediate immunologic selection pressure by both cytolytic and noncytolytic mechanisms. Non cytolytic mechanisms include the release of beta -chemokines blocking entry of R5 HIV-1 strains. In addition, CD8(+) cells inhibit X4 virus isolates via release of as yet poorly characterized soluble factors. To further characterize these factors, we performed detailed analysis of CTL as well as bulk CD8+ T lymphocytes from six HIV-1-infected individuals and from six HIV-1-seronegative individuals. Kinetic studies revealed that secreted suppressive activities of HIV-1-specific CTL and bulk CD8(+) T lymphocytes from all HIV-1-infected persons are significantly higher than that of supernatants from seronegative controls. The suppressive activity could be blocked by monensin and brefeldin A, was heat labile, and appeared in a pattern different from that of secretion of chemokines (MDC, I-309, MIP-1 alpha, MIP-1 beta, and RANTES), cytokines (gamma interferon, tumor necrosis factor alpha, and granulocytemacrophage colony-stimulating factor), and interleukins (interleukin-13 and interleukin-16). This suppression activity was characterized by molecular size exclusion centrifugation and involves a suppressive activity of > 50 kDa which could be bound to heparin and a nonbinding inhibitory activity of < 50 kDa. Our data provide a functional link between CD8(+) cells and CTL in the noncytolytic inhibition of HIV-1 and suggest that suppression of X4 virus is mediated through proteins. The sizes of the proteins, their affinity for heparin, and the pattern of release indicate that these molecules are not chemokines.
引用
收藏
页码:8306 / 8316
页数:11
相关论文
共 39 条
[1]   HIV SUPPRESSION BY INTERLEUKIN-16 [J].
BAIER, M ;
WERNER, A ;
BANNERT, N ;
METZNER, K ;
KURTH, R .
NATURE, 1995, 378 (6557) :563-563
[2]   Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes [J].
Bass, HZ ;
Fahey, JL ;
Nishanian, P ;
Detels, R ;
Cumberland, W ;
Kemeny, M ;
Plaeger, S .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (01) :64-69
[3]   The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry [J].
Bleul, CC ;
Farzan, M ;
Choe, H ;
Parolin, C ;
ClarkLewis, I ;
Sodroski, J ;
Springer, TA .
NATURE, 1996, 382 (6594) :829-833
[4]  
BRANDER C, 2000, HIV MOL IMMUNOLOGY D, V1, P1
[5]   Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca2+ signaling [J].
Burns, JM ;
Lewis, GK ;
DeVico, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (25) :14499-14504
[6]  
CHEN CC, 1993, ASIA PAC J PHARMACOL, V8, P1
[7]   A semiquantitative assay for CD8(+) T-cell-mediated suppression of human immunodeficiency virus type 1 infection [J].
Chen, Y ;
Rinaldo, C ;
Gupta, P .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (01) :4-10
[8]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[9]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[10]   CYTOKINES IN HIV-INFECTION [J].
EMILIE, D ;
FIOR, R ;
JARROUSSE, B ;
MARFAINGKOKA, A ;
MERRIEN, D ;
DEVERGNE, O ;
CREVON, MC ;
MAILLOT, MC ;
GALANAUD, P .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1994, 16 (5-6) :391-396